Description 

For psychiatric conditions such as treatment resistant depression, severe OCD and chronic PTSD, effective treatment can be challenging as specialized psychotherapy is often hard to access and medications, even in combination with therapy, do not work for a significant segment of patients. Furthermore, traditional therapy and oral medications take a relatively long time to work. In recent years, the multidisciplinary field of interventional psychiatry has made significant progress in the development of more rapid acting and precise treatments such as accelerated neuronavigated transcranial magnetic stimulation (SNT TMS) and stellate ganglion blocks (SGB) that offer patients and clinicians a new paradigm to achieve fast remission of symptoms and kickstart a longer process of healing through the use of evidence-based comprehensive treatment plans.  During our session, we will provide clinicians with an overview of these innovative, well-tolerated and promising interventional approaches that are typically taught minimally, if at all, in most training programs. We will utilize interactive polling to gauge participants’ familiarity and attitudes regarding traditional and SNT TMS and the SGB. We will also discuss the logistical and financial barriers to accessing these treatments, ways to navigate the current payment models to maximize access and what we can expect from the FDA’s breakthrough therapy pathway in the future. If mental health professionals knew more about how these treatments work, which patients could benefit from them and how to access them through strategic collaborations with anesthesiologists, interventional psychiatrists, technologists and payers, we could provide more meaningful recovery for patients with a wide range of mental health concerns. The innovative speakers in our session include an anesthesiologist who is considered the pioneer of the SGB treatment for PTSD, an adult and child psychiatrist who works at the intersection of healthcare informatics and care operations, a clinician-researcher who is triple board-certified in neurology, psychiatry and behavioral neurology and neuropsychiatry that is a world-renowned expert in neuromodulation, and an adult and child psychiatrist who has extensive experience with navigating the complexities of the payer landscape.

Format 

Recorded webinar.

This content was recorded during the APA 2023 Annual Meeting.

Learning Objectives 

1. Appreciate the potential of accelerated neuronavigated transcranial magnetic stimulation to effectively and safely treat depression within days instead of weeks to months
2. Understand the risks, benefits and logistics of incorporating a Stellate Ganglion Block, a precision medicine intervention by an anesthesiologist, as part of a comprehensive treatment plan for PTSD
3. Describe how the FDA granting an FDA clearance or a Breakthrough Therapy designation to a psychiatric drug or device impacts its accessibility and affordability for patients
4. Recognize the importance of collecting real world evidence and building networks of innovative clinicians committed to the implementation and advancement of interventional psychiatric approaches

Target Audience 

Medical Students, Residents/Fellows, Psychiatrists, non-psychiatrist Physicians

Estimate Time to Complete 

Estimated Duration: 1.5 hours
Program Start Date: May 1, 2025
Program End Date: May 1, 2028

How to Earn Credit 

Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned. 

Continuing Education Credit  

In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

The APA designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Faculty and Planner Disclosures 

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. 

Instructors 

• Carlene MacMillian, MD
• Nolan Williams, MD
• Owen Muir, MD
• Eugene Lipov, MD

Planners  

• Vishal Madaan, MD, Chief of Education and Deputy Medical Director at the American Psychiatric Association.

Accessibility for Participants with Disabilities 

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar. 

Technical Requirements 

This internet-based CME activity is best experienced using any of the following: 

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari 
• Internet Explorer 11+ 

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player. 

Optimal System Configuration: 

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version) 
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version) 
• Internet Connection: 1 Mbps or higher 

Minimum Requirements: 

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content 
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content 

For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance